Other Issues

In a new letter, ACI and CHPA call on FDA to withdraw its temporary guidance for the manufacturing of alcohol-based hand sanitizer products.

CHPA applauds FDA’s recent emergency use authorization for a number of over-the-counter (OTC) nonprescription self-testing products for COVID-19.

CHPA released the following statement in response to new research published in Clinical Toxicology. The study found nine illegal stimulants, including deterenol, in fraudulently marketed sports and weight loss supplements.

In a major victory for consumer health, today Mississippi has repealed an 11-year-old law that banned over-the-counter (OTC) sales of certain medicines for colds and allergies containing the decongestant pseudoephedrine (PSE).

CHPA, along with a wide coalition of organizations, co-signed a joint press release in support of the re-introduction of this bipartisan CBD bill.

Recent media reports have cited infectious disease experts who recommend against premedicating with over-the-counter (OTC) pain relievers, like those containing acetaminophen and ibuprofen, when getting a COVID-19 vaccine.